The University of Southampton
University of Southampton Institutional Repository

Use of inhaled corticosteroids and risk of fractures

Use of inhaled corticosteroids and risk of fractures
Use of inhaled corticosteroids and risk of fractures
Treatment with systemic corticosteroids is known to increase the risk of fractures but little is known of the fracture risks associated with inhaled corticosteroids. A retrospective cohort study was conducted using a large UK primary care database (the General Practice Research Database [GPRD]). Inhaled corticosteroid users aged 18 years or older were compared with matched control patients and to a group of noncorticosteroid bronchodilator users. Patients with concomitant use of systemic corticosteroids were excluded. The study comprised 170,818 inhaled corticosteroid users, 108,786 bronchodilator users, and 170,818 control patients. The average age was 45.1 years in the inhaled corticosteroid, 49.3 years in the bronchodilator, and 45.2 years in the control groups. In the inhaled corticosteroid cohort, 54.5% were female. The relative rates (RRs) of nonvertebral, hip, and vertebral fractures during inhaled corticosteroid treatment compared with control were 1.15 (95% CI, 1.10-1.20), 1.22 (95% CI, 1.04-1.43), and 1.51 (95% CI, 1.22-1.85), respectively. No differences were found between the inhaled corticosteroid and bronchodilator groups (nonvertebral fracture RR = 1.00; 95% CI, 0.94-1.06). The rates of nonvertebral fractures among users of budesonide (RR = 0.95; 95% CI, 0.85-1.07) and fluticasone propionate (RR = 1.03; 95% CI, 0.71-1.49) were similar to the rate determined for users of beclomethasone dipropionate. We conclude that users of inhaled corticosteroids have an increased risk of fracture, particularly at the hip and spine. However, this excess risk may be related more to the underlying respiratory disease than to inhaled corticosteroid.
osteoporosis, corticosteroid, epidemiology, fracture, inhaled
0884-0431
581-588
Van Staa, T.P.
31b8bfb4-4e1b-4a48-a5a6-90ca601b94af
Leufkens, H.G.M.
04854167-bea6-4508-a8e2-aeb920a2d6b1
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Van Staa, T.P.
31b8bfb4-4e1b-4a48-a5a6-90ca601b94af
Leufkens, H.G.M.
04854167-bea6-4508-a8e2-aeb920a2d6b1
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6

Van Staa, T.P., Leufkens, H.G.M. and Cooper, C. (2001) Use of inhaled corticosteroids and risk of fractures. Journal of Bone and Mineral Research, 16 (3), 581-588. (doi:10.1359/jbmr.2001.16.3.581).

Record type: Article

Abstract

Treatment with systemic corticosteroids is known to increase the risk of fractures but little is known of the fracture risks associated with inhaled corticosteroids. A retrospective cohort study was conducted using a large UK primary care database (the General Practice Research Database [GPRD]). Inhaled corticosteroid users aged 18 years or older were compared with matched control patients and to a group of noncorticosteroid bronchodilator users. Patients with concomitant use of systemic corticosteroids were excluded. The study comprised 170,818 inhaled corticosteroid users, 108,786 bronchodilator users, and 170,818 control patients. The average age was 45.1 years in the inhaled corticosteroid, 49.3 years in the bronchodilator, and 45.2 years in the control groups. In the inhaled corticosteroid cohort, 54.5% were female. The relative rates (RRs) of nonvertebral, hip, and vertebral fractures during inhaled corticosteroid treatment compared with control were 1.15 (95% CI, 1.10-1.20), 1.22 (95% CI, 1.04-1.43), and 1.51 (95% CI, 1.22-1.85), respectively. No differences were found between the inhaled corticosteroid and bronchodilator groups (nonvertebral fracture RR = 1.00; 95% CI, 0.94-1.06). The rates of nonvertebral fractures among users of budesonide (RR = 0.95; 95% CI, 0.85-1.07) and fluticasone propionate (RR = 1.03; 95% CI, 0.71-1.49) were similar to the rate determined for users of beclomethasone dipropionate. We conclude that users of inhaled corticosteroids have an increased risk of fracture, particularly at the hip and spine. However, this excess risk may be related more to the underlying respiratory disease than to inhaled corticosteroid.

This record has no associated files available for download.

More information

Published date: 2001
Keywords: osteoporosis, corticosteroid, epidemiology, fracture, inhaled

Identifiers

Local EPrints ID: 26059
URI: http://eprints.soton.ac.uk/id/eprint/26059
ISSN: 0884-0431
PURE UUID: 5ae78b20-3f84-4961-a039-54fa83935b83
ORCID for C. Cooper: ORCID iD orcid.org/0000-0003-3510-0709

Catalogue record

Date deposited: 24 Apr 2006
Last modified: 18 Mar 2024 02:44

Export record

Altmetrics

Contributors

Author: T.P. Van Staa
Author: H.G.M. Leufkens
Author: C. Cooper ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×